Glenmark gets USFDA nod for generic high blood pressure drug ...Middle East

Drug firmGlenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator for its generic Diltiazem Hydrochloride extended release capsules used for treatment of high blood pressure. The company has received final approval from the United States Food & Drug Administration (USFDA) for Diltiazem Hydrochloride extended-release capsules USP, in the strengths of 60 mg, 90 mg, and 120 mg, Glenmark said in a statement. The product is a generic version of Biovail Laboratories Inc's Cardizem SR extended-release capsules in the same strengths, it added. The company has been granted a competitive generic therapy (CGT) designation for these capsules, therefore, with thisapp

Hence then, the article about glenmark gets usfda nod for generic high blood pressure drug was published today ( Tuesday 23/03/2021 - 12:16 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Glenmark gets USFDA nod for generic high blood pressure drug )

Also on site :

• Marvion Inc. Delivers Breakout Year with 100%+ Revenue Growth and Return to Profitability, Positioned for Accelerated Expansion
• US services sector growth slows in March
• Dmitriev: Europe ignores energy crisis, is approaching disaster